Reported Late Monday Feb.27, South Korea's GC Biopharma, Announced Today That It Has Signed An Asset Purchase Agreement With Catalyst Biosciences To Acquire 3 Programs Related To The Orphan Hematology
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
